Fund comparison · from official SEC filings
BIB vs TBXU: how much do they overlap?
ProShares Ultra Nasdaq Biotechnology and Direxion Daily Biotech Top 5 Bull 2X ETF
vs
Shared holdings
Company
BIB
TBXU
?
—N/A
17.83%
-6.28%
A
ARGXARGENX SE - ADR
1.33%
10.26%
R
REGNREGENERON PHARMACEUTICALS
3.57%
8.69%
A
AMGNAMGEN INC
4.99%
8.68%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
8.36%
G
GILDGILEAD SCIENCES INC
5.19%
8.28%
Only in BIB
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
?
—Repurchase Agreement
3.50%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
R
RVMDREVOLUTION MEDICINES INC
1.74%
B
BIIBBIOGEN INC
1.61%
I
ILMNILLUMINA INC
1.39%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
I
INSMINSMED INC
1.29%
R
ROIVROIVANT SCIENCES LTD
1.20%
I
INCYINCYTE CORP
1.08%
V
VTRSVIATRIS INC
1.05%
M
MRNAMODERNA INC
1.04%
G
GHGUARDANT HEALTH INC
0.95%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
E
EXELEXELIXIS INC
0.73%
B
BBIOBRIDGEBIO PHARMA INC
0.72%
M
MEDPMEDPACE HOLDINGS INC
0.71%
I
IONSIONIS PHARMACEUTICALS INC
0.71%
A
AXSMAXSOME THERAPEUTICS INC
0.67%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.64%
Only in TBXU
?
—DREYFUS GOVERNMENT CASH MANAGE
30.53%
?
—GOLDMAN FINANCIAL
25.97%
?
—GOLDMAN SACHS LIQ ES FD A
5.51%
Hold BIB and TBXU together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
BIB vs IBBQInvesco Nasdaq Biotechnology ETF
70% overlap
BIB vs IBBiShares Biotechnology ETF
53% overlap
TBXU vs BBHVanEck Biotech ETF
38% overlap
BIB vs UWMProShares Ultra Russell2000
34% overlap
BIB vs URTYProShares UltraPro Russell2000
33% overlap
TBXU vs HCMTDirexion HCM Tactical Enhanced US ETF
30% overlap
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
Informational and educational only — not investment advice.